NCT03938961 (Nutri-ICU-LS) is a clinical trial in Critically Ill, sponsored by Centre Hospitalier Universitaire Vaudois.

Who is sponsoring NCT03938961?

NCT03938961 is sponsored by Centre Hospitalier Universitaire Vaudois.

What condition does NCT03938961 study?

NCT03938961 studies Critically Ill.

Is NCT03938961 still recruiting?

NCT03938961 is currently completed. Last updated 14 April 2020.

Last reviewed 2020-04-14 · How we verify

NCT03938961: Nutri-ICU-LS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metabolic and Nutritional Characteristics of Long-stayer ICU Patients

Completed Last updated 14 April 2020

What this trial tests

trial in Critically Ill in 205 participants. Completed in 13 April 2020.

Timeline

1 February 2017

Primary endpoint
13 April 2020

13 April 2020

Quick facts

Lead sponsor	Centre Hospitalier Universitaire Vaudois
Status	Completed
Study type	OBSERVATIONAL
Enrollment	205
Start date	1 February 2017
Primary completion	13 April 2020
Estimated completion	13 April 2020
Sites	1 location across Switzerland

Conditions studied

Critically Ill — all drugs for Critically Ill →

Sponsor

Centre Hospitalier Universitaire Vaudois

Who can join

18 and older, any sex, with Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intensive care (ICU) patient population has increasing number of very long ICU stays. Long-stayers are usually defined as requiring more than 1 week of mechanical ventilation and of ICU therapy: little is know about their metabolic characteristics and their relation to outcome. The study aims at describing the demographic, nutritional and metabolic aspects of their stay. Analysis of 200-250 consecutive patients admitted to the ICU long-stayer program.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Metabolic and Nutritional Characteristics of Long-Stay Critically Ill Patients.
Viana MV, Pantet O, Bagnoud G, Martinez A, et al · · 2019 · cited 23× · PMID 31284633 · DOI 10.3390/jcm8070985
Specific nutrition and metabolic characteristics of critically ill patients with persistent COVID-19.
Viana MV, Pantet O, Charrière M, Favre D, et al · · 2022 · cited 8× · PMID 35048374 · DOI 10.1002/jpen.2334

Verify or expand the search:

Other recruiting trials for Critically Ill

Currently open trials in the same condition.

NCT07222007 — Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients · recruiting
NCT07143695 — Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion · NA · recruiting
NCT06473844 — Efficacy of SGLT2 Inhibitors in Adults With Sepsis · NA · recruiting
NCT05055830 — Opportunistic PK/PD Trial in Critically Ill Children (OPTIC) · recruiting
NCT05112328 — The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding · NA · recruiting

Other Centre Hospitalier Universitaire Vaudois trials

Trials by the same sponsor.

NCT07427511 — SwissNeuroRehab - HDHI · NA · recruiting
NCT07263438 — Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a · Phase 2 · recruiting
NCT07139756 — Deciphering the Mechanisms of Central BP Regulation in Patients With PD Associated With Orthostatic Hypotension · not yet recruiting
NCT07109388 — Comparison of Pericapsular Nerve Group (PENG) Block With a Combined Femoral, Sciatic, Lateral Femoral Cutaneous Nerve Bl · NA · not yet recruiting
NCT07268378 — Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03938961 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Vaudois
Last refreshed: 14 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03938961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing